Table 1.
Phenotype | Memory | Mild | Moderate | Severe |
---|---|---|---|---|
Adults
(6–65 years) |
Initially > 70% of serotypes > 0·35 µg/ml but response lost in 6 months | Multiple serotypes < 0·35 µg/ml or inability to increase > 70% of serotypes by > twofold | < 70% of serotypes > 0·35 µg/ml but protective titre to 3 or more serotypes | Protective titres to no more than 2 serotypes and titre if present is low (< 0·35 µg/ml) |
Children
(2–5 years) |
Initially > 50% of serotypes > 0·35 µg/ml but response lost in 6 months | Multiple serotypes < 0·35 µg/ml or inability to increase > 70% of serotypes by > twofold | < 50% of serotypes > 0·35 µg/ml but protective titre to 3 or more serotypes | Protective titres to no more than 2 serotypes and titre if present is low (< 0·35 µg/ml) |
Mild phenotype assumes pre‐vaccination titres are less than threshold levels (< 0·35 µg/ml) and there may be a response to a second Pneumovax II booster. All phenotypes assume a history of infection. (PPV = pneumococcal polysaccharide vaccine.